SPONSOR
National University Hospital, Singapore
Total Trials
7
Recruiting
7
Phases
Phase 3, Phase 2
Conditions studied: Postoperative DeliriumAgingMyocardial InjuryTuberculosisAcute Coronary SyndromePulmonary Hypertension (Diagnosis)Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM)Solid Organ MalignanciesNon-Small Cell Lung CancerEpidermal Growth Factor Receptor Mutation
National University Hospital, Singapore is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Postoperative Delirium, Aging, Myocardial Injury, Tuberculosis.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National University Hospital, Singapore
How many clinical trials has National University Hospital, Singapore sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by National University Hospital, Singapore, of which 7 are actively recruiting participants. These trials cover conditions including Postoperative Delirium, Aging, Myocardial Injury. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National University Hospital, Singapore research focus on?
National University Hospital, Singapore clinical trials span Postoperative Delirium, Aging, Myocardial Injury, Tuberculosis, Acute Coronary Syndrome, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National University Hospital, Singapore clinical trial?
To participate in a National University Hospital, Singapore trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National University Hospital, Singapore trials with current recruitment status updated daily.
Clinical Trials by National University Hospital, Singapore
NCT04792554
Recruiting
Singapore Perioperative Ageing Study (Sing-PAS)
Postoperative Delirium
NCT05473520 Phase 3
Recruiting
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Tuberculosis
NCT07241221
Recruiting
Antenatal Myo-inositol Supplementation in Pre-existing Diabetes
Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM)
NCT05719428 Phase 2
Recruiting
Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies
Solid Organ Malignancies
NCT04909073
Recruiting
Observational Study of Afatinib 30 mg Daily
Non-Small Cell Lung Cancer
NCT07091175 Phase 2
Recruiting
Dupilumab Therapy in Nephrotic Syndrome in Children
Nephrotic Syndrome in Children
NCT05921175
Recruiting
Transcutaneous Spinal Cord Stimulation With Robotic Gait Training in Chronic SCI
Spinal Cord Injury
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology